Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 21 - 30 of 100+ results
Oncology
31 years of experience
Clinical Oncology

Dr Beatrice Seddon is consultant on the Sarcoma Unit at University College Hospital, which together with the Bone Tumour Unit at the Royal National Orthopaedic Hospital, comprises the London Bone and Soft Tissue Tumour Service.

Dr Seddon trained in treating sarcomas at the Royal Marsden and Middlesex Hospitals in London, and now specialises exclusively in the treatment of soft tissue and bone sarcomas with chemotherapy and radiotherapy.

She completed her PhD (University of London) at the Institute of Cancer Research in imaging of tumour hypoxia, and currently has a strong interest in clinical trials in sarcoma, acting as principal and chief investigator for a number of national and international trials. She is actively involved in coordinating sarcoma research at a national level as a member of the NCRN Sarcoma Clinical Studies Group, and is also a member of the EORTC Soft Tissue and Bone Sarcoma Group. She regularly teaches and lectures on the management of sarcomas.

 

 


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Radiotherapy

 

  • Bone Cancer
  • Sarcoma

 

Read more
Oncology
36 years of experience
Medical Oncology

Professor Paul Ellis is a Consultant Medical Oncologist based in London, UK. He has a specialist interest in research into novel therapies in breast cancer management was heavily involved in chairing the UK Dept. of Health Advisory committee on the introduction of Herceptin into UK clinical practise, co-authoring the national guidelines of its use.

 

After attaining his Medical Degree from Otago University, New Zealand he then moved to London to complete his fellowship in Medical Oncology and postgraduate research degree at the Royal Marsden Hospital. It was here he submitted his MD thesis on the biological predictors of response to primary chemotherapy. 

 

Professor Paul Ellis continues to take an active leadership role within the UK and European Clinical Trials community. He was the principal investigator and co-chair in the trial management group for the UK National Adjuvant Chemotherapy (TACT) Trial and has been heavily involved on the Steering Committees of numerous other clinical trials of novel anti-cancer therapies including recently being Co-PI on the MARIANNE and KAMILLA trials. 

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more

Professor John Bridgewater is a Consultant Medical Oncologist and Clinical Researcher at the UCL Cancer Institute. He specialises in gastrointestinal oncology, with a particular interest in biliary tract cancers and carcinomas of unknown primary origin.

After studying medicine at Oxford and University College London, he went on to specialise in Medical Oncology at the Middlesex, Mount Vernon and Royal Marsden Hospital. He was awarded a PhD by the Institute of Cancer Research for research into gene therapy. In 1999 he was appointed as a Senior Lecturer in Medical Oncology at UCL.

Professor Bridgewater leads the National Cancer Research Institute subgroup in hepatobiliary malignancy and also has a laboratory programme at the UCL Cancer Institute investigating carcinoma of unknown primary origin. He is also active in trials across the gastrointestinal portfolio and has been the chief investigator on a number of landmark studies into gastrointestinal and biliary tract cancers. As well as his clinical and research work, he also serves on a number of committees including The National Institute for Health and Care Excellence (NICE) and National Cancer Research Institute (NCRI). 


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Bilary Cancer 
  • Bowel Cancer 
  • Cancer Unknown Primary
  • Gastro-intestinal Cancers
  • Liver Cancer 

 

Read more
Oncology
19 years of experience
Medical Oncology

Dr Gerlinger is a Consultant Medical Oncologist specializing in the treatment of oesophageal, stomach and bowel cancers. He leads the Translational Oncogenomics Research Team at the Institute of Cancer Research, London. 

He studied Medicine at the University of Munich, at Harvard Medical School, and at Imperial College London and obtained his research MD from the Institute of Immunology at the University in Munich. He trained in General Medicine and Medical Oncology at the University Hospital Zurich, Switzerland, at University College Hospital, The Royal Marsden Hospital and St Bartholomew’s Hospital in London. He undertook post-doctoral research training in cancer immunotherapy in Zurich and in cancer genomics and biomarker discovery at the Cancer Research UK London Research Institute. 

He became a Consultant Medical Oncologist at St Bartholomew’s Hospital in London in 2012. In 2013 he joined The Royal Marsden Hospital as a Consultant in Gastrointestinal Oncology and the Institute of Cancer Research to lead a research group developing new immunotherapies and targeted therapies for drug-resistant cancers. He is developing and leading clinical trials based on research discoveries from his laboratory and other labs worldwide.

Read more
Dr Naomi Fersht

Dr Naomi Fersht

1.29 miles

Dr Naomi Fersht

1.29 miles
Oncology
28 years of experience

Dr Naomi Fersht is a consultant clinical oncologist at University College Hospital and the National Hospital for Neurology and Neurosurgery. She specialises exclusively in the management of primary and secondary brain and spinal tumours. This involves the use of both conventional and innovative radiotherapy techniques and chemotherapy.

Her special interests are brain oligometastases; meningiomas; pituitary tumours; the management of teenagers and young adults with brain tumours; and advanced radiotherapy techniques including radiosurgery.

She qualified from the University of Cambridge and her specialist training was at the Royal Marsden and University College Hospitals. Naomi's doctoral thesis, supervised by Nobel Laureate Sir Paul Nurse, was in cell cycle checkpoints.


Diseases, Medical Tests and Treatments
  • Brain oligometastases
  • Meningiomas
  • Pituitary tumours
  • The management of teenagers and young adults with brain tumours (age 16-24)
  • Advanced radiotherapy techniques including radiosurgery
Read more
Oncology
21 years of experience
Bowel Cancer, Breast Cancer, Clinical Oncology + 10more

Dr Tom Richards is a consultant clinical oncologist specialising in the treatment of gastrointestinal (GI) and breast cancers. He is the clinical lead of the GI and breast cancer radiotherapy units at University College London NHS Hospital (UCLH) and honorary consultant in Clinical Oncology at The Whittington NHS Hospital. Prior to his appointment at UCLH, he was Clinical Oncology consultant in the GI and breast units at St Bartholomew's and The Royal London NHS Hospitals.

He is an experienced oncologist treating oesophagus, stomach, liver, pancreaticobiliary, colorectal and breast cancers. His specialist expertise is the delivery of radiotherapy, chemotherapy and biological targeted drugs for cancers at these sites. His particular interest is in technical radiotherapy treatments using cyberknife and intensity-modulated radiotherapy and motion management techniques using 4D-CT radiotherapy planning, deep inspiratory breath-hold and image-guided radiotherapy.

After graduation from Imperial College School of Medicine in London, his subsequent general internal medicine training was at King's College Hospital, London. He undertook specialist oncology training at St Bartholomew's and The Royal Marsden Hospitals in London. In 2015 he was awarded a PhD from the University of London for clinical and translation research performed at The Institute of Cancer Research, King's College London and The Royal Marsden Hospital. He studied the mechanisms by which therapeutic radiation affects normal tissues and strategies to detect and reduce late toxicity after curative treatment. He was awarded the Johnson and Johnson clinical research prize in 2012 for work contributing to his PhD.

He is a fellow of the Royal College of Radiologists and a member of The Royal College of Physicians, ESMO and ESTRO. He has spoken and chaired sessions at numerous national and international meetings. He is course tutor and examiner for the Institute of Cancer research MSc course and is the local principal investigator for several GI cancer clinical trials. Dr Richards is passionate to improve cancer outcomes, develop clinical research and deliver innovative multi-modality cancer treatments.


Diseases, Medical Tests and Treatments

  • Radiotherapy
  • Chemotherapy
  • SABR/Cyberknife
  • Intensity-modulated radiotherapy
  • SIRT (internal liver-directed radiotherapy)
  • Breast cancer
  • Colon cancer
  • Rectal cancer
  • Anal cancer
  • Oesophageal cancer
  • Liver cancer
  • Pancreatico-biliary cancer


Read more
Oncology
Offers video consultation
29 years of experience
Thyroid Cancer, Cancer of the Head, Neck, Mouth, and Tongue, Lung Cancer + 7more

Professor Nutting is providing COVID-safe telephone and video consultations for cancer patients requiring a second opinion during this difficult time.

Professor Christopher Nutting is a Consultant Clinical Oncologist based at The Royal Marsden Chelsea and Sutton, where he has both a private and NHS practice. 

Professor Nutting completed his undergraduate training at the University of London in 1992 and he went on to become a member of the Royal College of Physicians and a Fellow of the Royal College of Radiologists. Professor Nutting qualified as an oncologist and achieved a Medical Doctorate at The Institute of Cancer Research, University of London.

Professor Nutting has a special interest in medical education and in 2001 he was appointed Honorary Senior Lecturer in Clinical Oncology at The Institute of Cancer Research. In 2002 he assumed the role of Teacher at the University of London and Head of the Head and Neck Unit at The Royal Marsden.

Professor Nutting is National Clinical Lead in Head and Neck Cancer for the UK Department of Health and the Cancer Services Collaborative. He is also President of the British Oncological Association and Chairman of the National Cancer Research Institute Committee for Head and Neck Cancer Research.

Professor Nutting is heavily involved in research trials and he has published over 300 research articles in his speciality.


Diseases, Medical Tests and Treatments

  • Chemotherapy
  • Radiotherapy
  • Intensity-modulated radiotherapy
  • Radioiodine treatment
  • Cyberknife
  • Head and neck cancers
  • Mouth cancer
  • Throat cancer
  • Thyroid cancer
  • Lung cancer
  • Skin cancer


Read more
Oncology
20 years of experience
Bowel Cancer, Clinical Oncology, Colon Cancer + 5more

Dr. Asad Qureshi is a Consultant Clinical Oncologist with many years of experience in the treatment of gastro-intestinal cancer, including oesophageal cancer, stomach cancer, colon cancer, rectal cancer, and anal cancer.

Dr. Qureshi earned his primary medical qualification at St Bartholomew's and The Royal London Hospital Medical School in 1995. Dr Qureshi then went on to undertake his specialist clinical oncology training at various renowned London hospitals Charing Cross Hospital, St Barts Hospital, Guy’s and St Thomas, and the The Royal Marsden. During this time, Dr Qureshi also completed a research degree in imagining sciences at King's College London evaluating novel radiotherapy techniques in the treatment of lung cancer. Upon completion of his training, Dr Qureshi was appointed Consultant at Guy’s and St Thomas Hospital in 2014, where he had a key role in the opening of the new Cancer Centre and has held senior management positions.

Dr Qureshi is also an active member of the scientific research community and has a keen interest in stereotactic and image-guided radiotherapy, for which he has written a number of peer-reviewed research articles. He is currently the principal investigator for various cancer clinical trials and is also an active member of the medical education community, being a clinical supervisor for clinical oncology junior doctors .

Read more
Oncology
Recommended by 1 specialist
33 years of experience
Clinical Oncology

Lucy Brazil is a Consultant Oncologist who has been with Guy’s and St Thomas’ and King’s College Hospitals since 2005. In 2007, she was awarded an MD for research into breast cancer genetics at the Institute of Cancer Research and Breakthrough Breast Cancer.

Dr Brazil trained in oncology at the Royal Marsden Hospital and Guy’s and St Thomas’ Hospitals. Her specialist interests include neuro-oncology particularly high grade glioblastoma multiforme and low grade glioma including oligodendroglioma and spinal tumours and breast cancer including management of brain metastases. Dr Brazil has expertise in radiotherapy both standard conformal and stereotactic techniques and including Cyberknife, Rapid-Arc and IMRT. She also oversees chemotherapy and endocrine treatments.

Dr Brazil is a member of the NCI National Cancer Institute Brain Tumour Clinical Studies Group and the EORTC European Organisation of Research and Treatment of Cancer Brain Tumour Group. She is chief investigator for the CODEL brain tumour study using chemotherapy and radiotherapy for grade 3 gliomas, chairman of the brain-tumour palliative care sub-group and neuro-oncology research lead at Guy's and St Thomas' in addition to being systemic chemotherapy neuro-oncology lead at the hospital.

 


Diseases, Medical Tests and Treatments
  • Radiotherapy
  • Chemotherapy
  • Immunotherapy
  • Palliative Care
  • Brain Cancer
  • Breast Cancer
  • Neuro-oncology
Read more
Oncology
22 years of experience
Medical Oncology

I am a Medical Oncology Consultant for the Gastrointestinal Oncology Service at University College London Hospitals NHS Foundation Trust and Honorary Associate Professor at the UCL Cancer Insitute. I treat oesophageal, stomach, small bowel, colorectal and hepatobiliary cancers, as well as cancers of unknown primary. I am the UCLH Clinical Lead for the Cancer of Unknown Primary (CUP) Service and the Acute Oncology Service.


My research interests include immunotherapy for GI malignancies and Cancer of Unknown Primary, with focus on clinical trials and translational research of these cancers. I am Chief Investigator or Principal Investigator for a number of  GI or CUP immuno-oncology Phase 2 and 3 trials, including KEYNOTE 177, KEYNOTE 859, KEYNOTE 811, KEYNOTE 975,  VESTIGE, POLEM and CUPISCO.


I am Chair of the NCRI MUO-CUP Workstream as part of the Living With and Beyond Cancer CSG, and a member of the NCRI Colorectal Advanced and Adjuvant Disease Subgroup. I am the Principal Investigator of the UCL-UCLH GI + CUP Cancer Translational Research Biobank and a collaborator with the GI Oncology and CUP subgroups at the UCL Cancer Institute and Francis Crick Institute. I am a member of ASCO, ESMO and the Association of Cancer Physicans (UK).


I strongly believe in clinicians being educators and enjoy teaching oncology to UCL medical students, oncology and non-oncology junior trainees. I also give talks nationally and abroad at conferences and other hospitals to share best practice and future perspectives in the fields of GI oncology research, CUP, immunotherapy and novel trial designs.


To make an appointment or enquiry please contact my secretary Alanna Sarwar on asarwar@theloc.com or +44207 317 2659.


Diseases, Medical Tests and Treatments
  • Gastrointestinal Oncology - oesophageal, stomach, hepatobiliary and bowel cancers
  • Cancer of Unknown Primary
  • Acute Oncology
  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Clinical Trials
  • Immunotherapy
  • Gastrointestinal Oncology Research 
  • Cancer of Unknown Primary Research 
  • Molecular Profiling with solid and liquid biopsies
  • Biomarker Driven Clinical Trial Design and Implementation
Read more